hydrogen sulfide has been researched along with enkephalin, ala(2)-mephe(4)-gly(5)- in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bian, JS; Whiteman, M; Wood, M; Wu, ZY; Yang, HY | 1 |
Bian, JS; Wu, ZY; Yang, HY | 1 |
2 other study(ies) available for hydrogen sulfide and enkephalin, ala(2)-mephe(4)-gly(5)-
Article | Year |
---|---|
Hydrogen sulfide attenuates opioid dependence by suppression of adenylate cyclase/cAMP pathway.
Topics: Adenylyl Cyclases; Analgesics, Opioid; Animals; Behavior, Animal; Cell Line; Corpus Striatum; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Gene Expression Regulation; Humans; Hydrogen Sulfide; Male; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morphine; Morphine Dependence; Naloxone; Phosphorylation; Signal Transduction | 2014 |
Hydrogen sulfide inhibits opioid withdrawal-induced pain sensitization in rats by down-regulation of spinal calcitonin gene-related peptide expression in the spine.
Topics: Adenylyl Cyclases; Analgesics, Opioid; Animals; Calcitonin Gene-Related Peptide; Cell Line, Tumor; CREB-Binding Protein; Down-Regulation; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Humans; Hydrogen Sulfide; Hyperalgesia; Male; MAP Kinase Signaling System; Naloxone; Neuroblastoma; Pain Threshold; Rats; Rats, Sprague-Dawley; Spine; Substance Withdrawal Syndrome | 2014 |